WASHINGTON, March 27 -- Blood Advances, a medical journal that says it covers all aspects of hematology, including disorders of leukocytes, erythrocytes, platelets, hemostatic mechanisms, vascular biology, immunology and hematologic oncology from the American Society of Hematology, published research articles on the following topics in its April 12, 2022 edition:

CLINICAL TRIALS AND OBSERVATIONS:

* Optimal fludarabine lymphodepletion is associated with improved outcome . . .

Click here for more information about our products